EP 4103157 A1 20221221 - PHARMACEUTICAL COMPOSITION COMPRISING LINAGLIPTIN AND METFORMIN
Title (en)
PHARMACEUTICAL COMPOSITION COMPRISING LINAGLIPTIN AND METFORMIN
Title (de)
PHARMAZEUTISCHE ZUSAMMENSETZUNG MIT LINAGLIPTIN UND METFORMIN
Title (fr)
COMPOSITION PHARMACEUTIQUE CONTENANT DE LA LINAGLIPTINE ET DE LA METFORMINE
Publication
Application
Priority
- EP 20460012 A 20200213
- EP 2021053072 W 20210209
Abstract (en)
[origin: WO2021160608A1] The present invention relates to a pharmaceutical composition comprising the combination of linagliptin and metformin as active ingredients.
IPC 8 full level
A61K 9/20 (2006.01); A61K 31/133 (2006.01); A61K 31/155 (2006.01); A61K 31/522 (2006.01)
CPC (source: EP)
A61K 9/2009 (2013.01); A61K 9/2013 (2013.01); A61K 9/2027 (2013.01); A61K 9/2059 (2013.01); A61K 31/133 (2013.01); A61K 31/155 (2013.01); A61K 31/522 (2013.01)
Citation (search report)
See references of WO 2021160608A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
Designated validation state (EPC)
KH MA MD TN
DOCDB simple family (publication)
WO 2021160608 A1 20210819; CA 3170233 A1 20210819; EP 4103157 A1 20221221
DOCDB simple family (application)
EP 2021053072 W 20210209; CA 3170233 A 20210209; EP 21705444 A 20210209